• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-2、白细胞介素-15及其受体。

Interleukin-2, interleukin-15, and their receptors.

作者信息

Waldmann T, Tagaya Y, Bamford R

机构信息

Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Int Rev Immunol. 1998;16(3-4):205-26. doi: 10.3109/08830189809042995.

DOI:10.3109/08830189809042995
PMID:9505189
Abstract

Both IL-15 and IL-2 are 14-15 kDa members of the four alpha-helical bundle family of cytokines that have T cell growth factor activity. In contrast to the pattern manifested by IL-2, IL-15 mRNA is produced by a wide variety of tissues other than T cells. We have demonstrated that IL-15 expression is posttranscriptionally regulated by multiple elements, including the ten upstream AUGs of the 5' UTR, a 48aa signal peptide and the carboxy-terminus of the mature protein. IL-15 utilizes two distinct receptor signaling pathways. In T cells the IL-15 receptor includes IL-2R beta and gamma c subunits shared with IL-2 as well as an IL-15 specific receptor, IL-15R alpha. However, mast cells respond to IL-15 using a receptor system that does not share elements with the IL-2R system but involves a novel 60-65 kDa IL-15RX subunit. In mast cells, IL-15 signaling involves JAK-2 and STAT-5 activation rather than the JAK-1 and JAK-3 as well as the STAT-3 and STAT-5 used by both IL-2 and IL-15 in activated T cells.

摘要

IL-15和IL-2都是细胞因子的四α螺旋束家族中具有T细胞生长因子活性的14 - 15 kDa成员。与IL-2所表现出的模式不同,IL-15 mRNA由T细胞以外的多种组织产生。我们已经证明,IL-15的表达受到多种元件的转录后调控,包括5' UTR的十个上游AUG、一个48aa信号肽和成熟蛋白的羧基末端。IL-15利用两种不同的受体信号通路。在T细胞中,IL-15受体包括与IL-2共享的IL-2Rβ和γc亚基以及一个IL-15特异性受体IL-15Rα。然而,肥大细胞对IL-15的反应使用的受体系统与IL-2R系统没有共同元件,而是涉及一个新的60 - 65 kDa的IL-15RX亚基。在肥大细胞中,IL-15信号传导涉及JAK-2和STAT-5的激活,而不是IL-2和IL-15在活化T细胞中使用的JAK-1和JAK-3以及STAT-3和STAT-5。

相似文献

1
Interleukin-2, interleukin-15, and their receptors.白细胞介素-2、白细胞介素-15及其受体。
Int Rev Immunol. 1998;16(3-4):205-26. doi: 10.3109/08830189809042995.
2
The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens.白细胞介素-15表达的多方面调控以及该细胞因子在自然杀伤细胞分化和宿主对细胞内病原体反应中的作用。
Annu Rev Immunol. 1999;17:19-49. doi: 10.1146/annurev.immunol.17.1.19.
3
Early immune response and regulation of IL-2 receptor subunits.白细胞介素-2受体亚基的早期免疫反应与调控
Cell Signal. 2005 Sep;17(9):1111-24. doi: 10.1016/j.cellsig.2004.12.016. Epub 2005 Feb 25.
4
Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis.白细胞介素-15、白细胞介素-2及其受体在结节病肺脏T细胞肺泡炎发生中的作用
J Immunol. 1996 Jul 15;157(2):910-8.
5
Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex.白细胞介素-15与共享的白细胞介素-2受体β和γc亚基的相互作用。白细胞介素-15/β/γc受体-配体复合物比白细胞介素-2/β/γc受体-配体复合物稳定性更低。
J Immunol. 1996 Feb 15;156(4):1339-48.
6
Interleukin 15: its role in inflammation and immunity.白细胞介素15:其在炎症和免疫中的作用。
Arch Immunol Ther Exp (Warsz). 2000;48(6):457-64.
7
STAT-1 is activated by IL-4 and IL-13 in multiple cell types.信号转导和转录激活因子1(STAT-1)在多种细胞类型中被白细胞介素-4(IL-4)和白细胞介素-13(IL-13)激活。
Mol Immunol. 2004 Jul;41(9):873-84. doi: 10.1016/j.molimm.2004.04.027.
8
Physician Education: The Erythropoietin Receptor and Signal Transduction.医师教育:促红细胞生成素受体与信号转导
Oncologist. 1996;1(5):337-339.
9
The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor.白细胞介素-2受体γc链并非作为白细胞介素-4和白细胞介素-13受体共享的亚基发挥作用。这对白细胞介素-4受体结构的启示。
J Immunol. 1995 Jul 1;155(1):9-12.
10
IL-2-induced signal transduction involves the activation of nuclear NF-kappa B expression.白细胞介素-2诱导的信号转导涉及核因子κB表达的激活。
J Immunol. 1992 Jul 1;149(1):83-91.

引用本文的文献

1
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies.使用肿瘤靶向性白细胞介素-2细胞因子及其衍生物引发的抗癌免疫反应在临床前联合治疗中的疗效。
Vaccines (Basel). 2025 Jan 13;13(1):69. doi: 10.3390/vaccines13010069.
2
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy.转化性药代动力学/药效学与PD1/IL15的首次人体剂量选择:一种用于癌症免疫治疗的工程重组靶向细胞因子
Front Pharmacol. 2024 Jun 3;15:1380000. doi: 10.3389/fphar.2024.1380000. eCollection 2024.
3
Identification and expression analysis of IL-2 receptors in large yellow croaker ().
大黄鱼中白细胞介素-2受体的鉴定与表达分析
Fish Shellfish Immunol Rep. 2021 Mar 18;2:100008. doi: 10.1016/j.fsirep.2021.100008. eCollection 2021 Dec.
4
Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity.重编程自身反应性 T 细胞为 T 调节型 1 细胞,用于自身免疫病的治疗。
Front Immunol. 2021 Jul 15;12:684240. doi: 10.3389/fimmu.2021.684240. eCollection 2021.
5
Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells.Cbl-b 上调并在活化的人自然杀伤细胞中发挥负性作用。
J Immunol. 2021 Feb 15;206(4):677-685. doi: 10.4049/jimmunol.2000177. Epub 2021 Jan 8.
6
Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer.白细胞介素-15(异常)调节淋巴组织稳态:对自身免疫和癌症治疗的影响。
J Exp Med. 2020 Jan 6;217(1). doi: 10.1084/jem.20191062.
7
Differential Cytokine Utilization and Tissue Tropism Results in Distinct Repopulation Kinetics of Naïve vs. Memory T Cells in Mice.差异细胞因子利用和组织嗜性导致小鼠中幼稚 T 细胞与记忆 T 细胞的再群体动力学明显不同。
Front Immunol. 2019 Mar 4;10:355. doi: 10.3389/fimmu.2019.00355. eCollection 2019.
8
Oscillatory IL-2 stimulus reveals pertinent signaling timescales of T cell responsiveness.振荡的 IL-2 刺激揭示了 T 细胞响应的相关信号时间尺度。
PLoS One. 2018 Sep 18;13(9):e0203759. doi: 10.1371/journal.pone.0203759. eCollection 2018.
9
Prospects of IL-2 in Cancer Immunotherapy.IL-2 在癌症免疫治疗中的前景。
Biomed Res Int. 2018 May 6;2018:9056173. doi: 10.1155/2018/9056173. eCollection 2018.
10
Daclizumab Therapy for Multiple Sclerosis.达利珠单抗治疗多发性硬化。
Cold Spring Harb Perspect Med. 2019 May 1;9(5):a034470. doi: 10.1101/cshperspect.a034470.